- Home
- NOTE vs TPST Comparison
NOTE vs TPST Comparison
Compare NOTE & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- TPST
- Stock Information
- Founded
- NOTE 2013
- TPST 2011
- Country
- NOTE United States
- TPST United States
- Employees
- NOTE N/A
- TPST N/A
- Industry
- NOTE EDP Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- TPST Health Care
- Exchange
- NOTE Nasdaq
- TPST Nasdaq
- Market Cap
- NOTE 39.9M
- TPST 42.3M
- IPO Year
- NOTE N/A
- TPST N/A
- Fundamental
- Price
- NOTE $2.14
- TPST $9.21
- Analyst Decision
- NOTE Strong Buy
- TPST Hold
- Analyst Count
- NOTE 4
- TPST 3
- Target Price
- NOTE $29.25
- TPST $30.00
- AVG Volume (30 Days)
- NOTE 251.5K
- TPST 33.2K
- Earning Date
- NOTE 11-06-2025
- TPST 11-05-2025
- Dividend Yield
- NOTE N/A
- TPST N/A
- EPS Growth
- NOTE N/A
- TPST N/A
- EPS
- NOTE N/A
- TPST N/A
- Revenue
- NOTE $102,673,000.00
- TPST N/A
- Revenue This Year
- NOTE N/A
- TPST N/A
- Revenue Next Year
- NOTE $4.61
- TPST N/A
- P/E Ratio
- NOTE N/A
- TPST N/A
- Revenue Growth
- NOTE N/A
- TPST N/A
- 52 Week Low
- NOTE $2.05
- TPST $5.35
- 52 Week High
- NOTE $24.36
- TPST $13.65
- Technical
- Relative Strength Index (RSI)
- NOTE 18.97
- TPST 42.88
- Support Level
- NOTE $2.50
- TPST $8.51
- Resistance Level
- NOTE $3.28
- TPST $9.75
- Average True Range (ATR)
- NOTE 0.33
- TPST 0.68
- MACD
- NOTE -0.14
- TPST -0.09
- Stochastic Oscillator
- NOTE 7.94
- TPST 33.73
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.